Abstract
Biologic response modifiers have revolutionized the treatment of a number of chronic inflammatory diseases, including rheumatoid arthritis, seronegative spondyloarthropathies, psoriasis, and inflammatory bowel disease. The tumor necrosis factor-alpha (TNF-alpha) inhibitors have a targeted strategy for the treatment of systemic inflammation and improve patient symptoms and function. However, TNF-alpha has demonstrated importance in the protection against several pathogens, leaving patients on this therapy more prone to infections.
Original language | English (US) |
---|---|
Title of host publication | Challenging Cases and Complication Management in Pain Medicine |
Publisher | Springer International Publishing |
Pages | 103-108 |
Number of pages | 6 |
ISBN (Electronic) | 9783319600727 |
ISBN (Print) | 9783319600703 |
DOIs | |
State | Published - Jan 1 2017 |
Keywords
- Epidural abscess
- Epidural steroid injection
- Infection
- Tumor necrosis factor alpha
ASJC Scopus subject areas
- General Medicine